Getinge AB 

SEK209.7
25
+SEK1.1+0.53% Thursday 15:29

統計

當日最高
212.3
當日最低
207.3
52週最高
240.2
52週最低
174.85
成交量
728,771
平均成交量
635,833
市值
57.03B
市盈率
22.09
股息收益率
2.1%
股息
4.4

即將到來

股息

2.1%股息收益率
10年增長
0.59%
5年增長率
34.49%
3年增長率
13.62%
1年增長率
3.53%

收益

18Oct預期
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一個
0
1.14
2.29
3.43
預期每股收益
2.4515074255897513
實際每股收益
N/A

人們還關注

此列表基於在 Stock Events 上關注 GETI-B.ST 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

關於

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions. The company also provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, and drainage solutions; and operating room infrastructure equipment, anesthesia, advanced patient monitoring, operating room management, and operating room integration solutions. In addition, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices; bioreactor systems, DPTE systems, Getinge isolators, terminal sterilization products, and sterilizers; and vivarium, biohazardous materials handling solutions, labware cleaning and sterilization, upstream bioprocessing, and bioreactor preparation solutions. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.
Show more...
首席執行官
Mr. Mattias Perjos M.Sc.
員工
11891
國家
Sweden

上市公司